Prot #ADS-AMT-PD302: Open-Label Safety Study of ADS-5102(Amantadine HCL) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesa

Project: Research project

Project Details

StatusFinished
Effective start/end date7/23/157/23/18

Funding

  • Adamas Pharmaceuticals, Inc. (ADS-AMT-PD302)